KARD on Nasdaq

Kardigan, Inc.

American pharmaceutical preparations company, incorporated in Delaware. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with another stock.

  • TickerKARD on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersSouth San Francisco, California1
  • Incorporated inDE2
  • Business addressC/O Kardigan, Inc., 131 Oyster Point Blvd., Second Floor, South San Francisco, Ca 940802
  • Filer category, Emerging growth company2

Leadership

Who has led Kardigan, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (13)

Timeline

  1. Jun 18, 2026New chief executive Anastasios Gianakakos becomes CEO3

Filings

54 filings to the SEC since October 2021: 1 quarterly reports, 3 major events, 32 insider forms, 8 large holders, 10 other. The latest 20:

  1. Oct 1, 20264 EDGAR
  2. Oct 1, 20263 EDGAR
  3. Oct 1, 2026SCHEDULE 13D/A EDGAR
  4. Sep 30, 20268-K EDGAR
  5. Aug 13, 2026SCHEDULE 13G EDGAR
  6. Aug 13, 2026SCHEDULE 13G EDGAR
  7. Aug 11, 202610-Q EDGAR
  8. Aug 11, 20268-K EDGAR
  9. Aug 7, 2026SCHEDULE 13G/A EDGAR
  10. Aug 6, 2026SCHEDULE 13G EDGAR
  11. Jul 13, 20264 EDGAR
  12. Jun 29, 2026SCHEDULE 13G EDGAR
  13. Jun 29, 2026SCHEDULE 13D EDGAR
  14. Jun 25, 2026SCHEDULE 13D EDGAR
  15. Jun 24, 20264 EDGAR
  16. Jun 24, 20263/A EDGAR
  17. Jun 24, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  18. Jun 24, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  19. Jun 23, 20268-K EDGAR
  20. Jun 22, 20264 EDGAR

The 54 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 3 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 22, 2026HRTG PV, L.P.10% ownerBuy3,125,000$16.00$50.0MForm 4
Jun 22, 2026BERNS PAUL LDirectorBuy1,250,000$16.00$20.0MForm 4
Jun 22, 2026NELSEN ROBERTDirectorBuy1,250,000$16.00$20.0MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 68. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Hrtg Gpe, LLC16,917,034$403.5M16.3%New
Fmr LLC8,909,066$212.5M0.0%New
Perceptive Advisors LLC8,200,662$195.6M3.0%New
Capital Research Global Investors3,598,942$85.8M0.0%New
Jpmorgan Chase & Co1,790,734$46.4M0.0%New
Alliancebernstein L.P.1,534,837$36.6M0.0%New
Liberty Mutual Group Asset Management Inc.1,196,411$28.5M2.5%New
Jennison Associates LLC903,575$21.6M0.0%New
Paradigm Biocapital Advisors LP900,000$21.5M0.4%New
Jupiter Topco LLC749,703$17.7M0.0%New
Massachusetts Financial Services Co /ma/650,000$15.5M0.0%New
Goldman Sachs Group Inc644,969$15.4M0.0%New
Deep Track Capital, LP600,000$14.3M0.2%New
Woodline Partners LP413,980$9.9M0.0%New
Franklin Resources Inc400,021$9.5M0.0%New
Montanova Capital, LLC400,000$9.5M0.2%New
Bank of New York Mellon Corp377,758$9.0M0.0%New
Catalio Capital Management, LP312,500$7.5M1.4%New
Principal Financial Group Inc300,000$7.2M0.0%New
Eventide Asset Management, LLC300,000$7.2M0.1%New
Braidwell LP300,000$7.2M0.3%New
UBS Group AG267,760$6.4M0.0%New
Peregrine Capital Management LLC229,776$5.5M0.2%New
Millennium Management LLC223,065$5.3M0.0%New
Integral Health Asset Management, LLC200,000$4.8M0.2%New

13F reports cover disclosed long positions in U.S. stocks only.